>
pdufa.bio

Barzolvolimab

Updated ยทnext FDA decision on the calendar

Barzolvolimab is a Celldex Therapeutics, Inc. program. Its next catalyst is a Readout in Oct 2026. Every date links its source.

CLDX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Celldex Therapeutics, Inc. (CLDX). We track 3 catalyst events for this program: 3 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2026CLDXReadout · Mar 2027CLDXReadout · Apr 2027CLDX

Questions

When is Barzolvolimab's next FDA decision or readout?

The next tracked catalyst for Barzolvolimab is a Readout in Oct 2026.

What happened at Barzolvolimab's most recent FDA decision?

No FDA decision for Barzolvolimab is in our archive yet.

Who makes Barzolvolimab?

Celldex Therapeutics, Inc. (CLDX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.